Literature DB >> 31020546

A new alternative for intravenous lipid emulsion 20% w/w from superolein oil and its effect on lipid and liver profiles in an animal model.

Mohd Haz Hairul Amran1,2, Mohd Hanif Zulfakar1, Mohd Fairuz Danik1, Mohd Shakrie Palan Abdullah3,4, Ahmad Fuad Shamsuddin5,6.   

Abstract

PURPOSE: Intravenous lipid emulsion (IVLE) was first used to prevent essential fatty acids deficiency. IVLE with α-tocopherol was reported to provide protection against parenteral nutrition-associated liver disease. This study aims to determine the optimal parameters and conditions in developing a physically stable IVLE from superolein palm oil (SoLE 20%) and its effect on lipid and liver profiles in an animal model.
METHODS: SoLE 20% was prepared using superolein oil and MCT oil (1:1), stabilized with egg lecithin and homogenized using a high pressure homogenizer. Mean droplet size was used as the response variable and was measured using laser diffraction and dynamic light scattering method. Physical stability at 4 °C, 25 °C and 40 °C storage temperatures were determined based on particle size and distribution, polydispersity index, zeta potential, viscosity, vitamin E contents and pH. Sterility and pyrogenicity were also investigated. Rabbits were administered with 1.0 g/kg SoLE 20% for 5 h and repeated daily for 3 days to investigate its effect on blood lipid and liver enzymes profile.
RESULTS: SoLE 20% was succesfully prepared using the optimized parameters of 800 psi, 7 cycles and 1.2 g lecithin. The IVLE prepared had a particle size of 252.60 ± 4.88 nm and was physically stable for 4 weeks at different storage temperatures. SoLE 20% had a high content of natural vitamin E, remained sterile and pyrogen free. It was also safe for intravenous administration and did not alter the blood lipid (p > 0.05) and liver enzymes profiles (p > 0.05) of the rabbits.
CONCLUSION: The optimal parameters to develop a stable superolein based IVLE are 800 psi homogenization pressure, 7 homogenization cycles and using 1.2 g lecithin as the emulsifier. SoLE 20% is safe for intravenous administration and does not significantly alter lipid and liver enzymes profiles of the rabbits.

Entities:  

Keywords:  Egg lecithin; Intravenous lipid emulsion; MCT; Response surface methodology; Superolein palm oil

Mesh:

Substances:

Year:  2019        PMID: 31020546      PMCID: PMC6593023          DOI: 10.1007/s40199-019-00262-7

Source DB:  PubMed          Journal:  Daru        ISSN: 1560-8115            Impact factor:   3.117


  25 in total

1.  Development of industrially feasible concentrated 30% and 40% nanoemulsions for intravenous drug delivery.

Authors:  R H Müller; D Harden; C M Keck
Journal:  Drug Dev Ind Pharm       Date:  2011-11-16       Impact factor: 3.225

Review 2.  State of the art review: Intravenous fat emulsions: Current applications, safety profile, and clinical implications.

Authors:  Jay M Mirtallo; Joseph F Dasta; Kurt C Kleinschmidt; Joseph Varon
Journal:  Ann Pharmacother       Date:  2010-04       Impact factor: 3.154

3.  Sterile, injectable cyclodextrin nanoparticles: effects of gamma irradiation and autoclaving.

Authors:  Erem Memisoglu-Bilensoy; A Atilla Hincal
Journal:  Int J Pharm       Date:  2006-01-18       Impact factor: 5.875

4.  Globule-size distribution in injectable 20% lipid emulsions: Compliance with USP requirements.

Authors:  David F Driscoll
Journal:  Am J Health Syst Pharm       Date:  2007-10-01       Impact factor: 2.637

5.  Pharmacopeial compliance of fish oil-containing parenteral lipid emulsion mixtures: Globule size distribution (GSD) and fatty acid analyses.

Authors:  David F Driscoll; Pei-Ra Ling; Bruce R Bistrian
Journal:  Int J Pharm       Date:  2009-06-25       Impact factor: 5.875

6.  A.S.P.E.N. position paper: Clinical role for alternative intravenous fat emulsions.

Authors:  Vincent W Vanek; Douglas L Seidner; Penny Allen; Bruce Bistrian; Sharon Collier; Kathleen Gura; John M Miles; Christina J Valentine; Marty Kochevar
Journal:  Nutr Clin Pract       Date:  2012-02-29       Impact factor: 3.080

7.  Long-term physico-chemical stability of standard parenteral nutritions for neonates.

Authors:  Lucie Bouchoud; Farshid Sadeghipour; Martin Klingmüller; Caroline Fonzo-Christe; Pascal Bonnabry
Journal:  Clin Nutr       Date:  2010-05-21       Impact factor: 7.324

8.  Lipofundin-induced hyperlipidemia promotes oxidative stress and atherosclerotic lesions in new zealand white rabbits.

Authors:  Livan Delgado Roche; Emilio Acosta Medina; Angela Fraga Pérez; María A Bécquer Viart; Yosdel Soto López; Viviana Falcón Cama; Ana M Vázquez López; Gregorio Martínez-Sánchez; Eduardo Fernández-Sánchez
Journal:  Int J Vasc Med       Date:  2011-09-29

9.  Effect of dietary palm olein oil on oxidative stress associated with ischemic-reperfusion injury in isolated rat heart.

Authors:  Deepak Narang; Subeena Sood; Mathew Kadali Thomas; Amit Kumar Dinda; Subir Kumar Maulik
Journal:  BMC Pharmacol       Date:  2004-11-09

10.  Formulation optimization of a palm-based nanoemulsion system containing levodopa.

Authors:  Syafinaz Zainol; Mahiran Basri; Hamidon Bin Basri; Ahmad Fuad Shamsuddin; Siti Salwa Abdul-Gani; Roghayeh Abedi Karjiban; Emilia Abdul-Malek
Journal:  Int J Mol Sci       Date:  2012-10-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.